ChemoCentryx, Inc. Revenue
ChemoCentryx, Inc. reported Revenue of $600.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-09.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2021-11-09
- ChemoCentryx, Inc. revenues for the quarter ending 2021-09-30 was -$200.00K.
- ChemoCentryx, Inc. revenues for the quarter ending 2021-06-30 was $0.00.
- ChemoCentryx, Inc. revenues for the quarter ending 2018-03-31 was $9.55M, a 15.99% increase year-over-year.
- ChemoCentryx, Inc. revenues for the quarter ending 2017-12-31 was $56.30M, a 1051.59% increase year-over-year.
- ChemoCentryx, Inc. revenues for fiscal 2020 was $0.00.
- ChemoCentryx, Inc. revenues for fiscal 2017 was $82.50M, a 591.22% increase from fiscal 2016.
- ChemoCentryx, Inc. revenues for fiscal 2016 was $11.94M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2021-09-30 | -$200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$200.00K derived: sum of 2 quarters · filed 2021-11-09 | $600.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 | $800.00K 10-Q · filed 2021-08-09 | ||
| 2020-12-31 | $0.00 10-K · filed 2021-03-01 | |||
| 2018-03-31 | $9.55M 10-Q · filed 2018-05-09 | $65.85M derived: sum of 2 quarters · filed 2018-05-09 | $74.88M derived: sum of 3 quarters · filed 2018-05-09 | $83.81M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-12-31 | $56.30M 10-K · filed 2018-03-12 | $65.33M derived: sum of 2 quarters · filed 2018-03-12 | $74.27M derived: sum of 3 quarters · filed 2018-03-12 | $82.50M 10-K · filed 2018-03-12 |
| 2017-09-30 | $9.03M 10-K · filed 2018-03-12 | $17.97M derived: sum of 2 quarters · filed 2018-03-12 | $26.20M 10-Q · filed 2017-11-07 | $31.09M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-06-30 | $8.94M 10-K · filed 2018-03-12 | $17.17M 10-Q · filed 2017-08-08 | $22.06M derived: sum of 3 quarters · filed 2018-05-09 | $26.31M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-03-31 | $8.23M 10-Q · filed 2018-05-09 | $13.12M derived: sum of 2 quarters · filed 2018-05-09 | $17.37M derived: sum of 3 quarters · filed 2018-05-09 | $20.16M derived: sum of 4 quarters · filed 2018-05-09 |
| 2016-12-31 | $4.89M 10-K · filed 2018-03-12 | $9.14M derived: sum of 2 quarters · filed 2018-03-12 | $11.94M derived: sum of 3 quarters · filed 2018-03-12 | $11.94M 10-K · filed 2018-03-12 |
| 2016-09-30 | $4.25M 10-K · filed 2018-03-12 | $7.05M derived: sum of 2 quarters · filed 2018-03-12 | $7.05M 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $2.79M 10-K · filed 2018-03-12 | $2.79M 10-Q · filed 2017-08-08 | ||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-10 | |||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-10 | |||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-08 |